On February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achieving relevant improvements on the efficacy and tolerance of the treatments based on enzyme replacement therapies. Our technology transfer director Alba Córdoba will lead the session dealing with Production Optimization and Scale-up of the nanoformulation and our CEO Santi Sala will contribute to the final round table.
Online venue:
Further relevant information regarding the event will be provided on https://smart4fabry.eu/
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Horizon ha puesto en funcionamiento una nueva planta dedicada íntegra...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory